From October 1, 2022 to December 30, 2022, the company has repurchased 0 shares, representing 0% for CNY 0 million. With this, the company has completed the repurchase of 3,909,896 shares, representing 0.45% for CNY 369.4 million under the buyback announced on February 13, 2022.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
61.75 CNY | +4.47% | +3.49% | +12.33% |
04-25 | Hangzhou Tigermed Consulting’s Profit Down 59% in Q1 | MT |
04-25 | Hangzhou Tigermed Consulting Co., Ltd Reports Earnings Results for the First Quarter Ended March 30, 2024 | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+12.33% | 6.94B | |
+19.73% | 46.81B | |
-0.69% | 41.37B | |
+47.07% | 41.29B | |
-6.20% | 28.87B | |
+11.71% | 26.06B | |
-19.81% | 19.13B | |
+32.64% | 12.39B | |
+0.40% | 12.08B | |
+0.48% | 11.96B |
- Stock Market
- Equities
- 300347 Stock
- News Hangzhou Tigermed Consulting Co., Ltd
- Tranche Update on Hangzhou Tigermed Consulting Co., Ltd.'s Equity Buyback Plan announced on February 13, 2022.